Atlas Trials

Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance

Clinical trial NCT06471088 · UNKNOWN

Trial details

NCT number
NCT06471088
Sponsor
Viatris Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Dovprela
Start date
2023-07-23
Primary completion
2026-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.